Loretto Lacey

979 total citations
37 papers, 794 citations indexed

About

Loretto Lacey is a scholar working on Economics and Econometrics, Psychiatry and Mental health and Epidemiology. According to data from OpenAlex, Loretto Lacey has authored 37 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Economics and Econometrics, 19 papers in Psychiatry and Mental health and 10 papers in Epidemiology. Recurrent topics in Loretto Lacey's work include Health Systems, Economic Evaluations, Quality of Life (21 papers), Dementia and Cognitive Impairment Research (19 papers) and Chronic Disease Management Strategies (6 papers). Loretto Lacey is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (21 papers), Dementia and Cognitive Impairment Research (19 papers) and Chronic Disease Management Strategies (6 papers). Loretto Lacey collaborates with scholars based in United Kingdom, United States and Ireland. Loretto Lacey's co-authors include Damien Gallagher, Brian Lawlor, Lisa Crosby, Áine Ní Mhaoláin, Robert F. Coen, Conal Cunningham, Davis Coakley, Cathal Walsh, Timothy Niecko and Martin Buxton and has published in prestigious journals such as Gastroenterology, Neurology and Age and Ageing.

In The Last Decade

Loretto Lacey

36 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Loretto Lacey United Kingdom 17 429 282 260 163 124 37 794
Cadja Bachmann Germany 17 432 1.0× 457 1.6× 104 0.4× 83 0.5× 74 0.6× 23 959
Allan Gustavo Brígola Brazil 15 243 0.6× 168 0.6× 93 0.4× 83 0.5× 216 1.7× 29 653
Carla J.M. Schölzel-Dorenbos Netherlands 11 366 0.9× 301 1.1× 130 0.5× 98 0.6× 39 0.3× 12 567
KlaasJan Hajema Netherlands 13 125 0.3× 236 0.8× 98 0.4× 62 0.4× 157 1.3× 19 651
Marisa Silvana Zazzetta Brazil 17 156 0.4× 362 1.3× 103 0.4× 105 0.6× 217 1.8× 72 900
Anne‐Marie Burn United Kingdom 11 236 0.6× 262 0.9× 64 0.2× 55 0.3× 101 0.8× 41 689
Silke Mamone Germany 14 156 0.4× 198 0.7× 71 0.3× 60 0.4× 114 0.9× 27 555
Ana Carolina Ottaviani Brazil 15 200 0.5× 241 0.9× 50 0.2× 123 0.8× 106 0.9× 72 709
Claudio Bilotta Italy 13 119 0.3× 267 0.9× 193 0.7× 54 0.3× 317 2.6× 19 730
Joseph Parks United States 14 264 0.6× 188 0.7× 62 0.2× 44 0.3× 33 0.3× 40 678

Countries citing papers authored by Loretto Lacey

Since Specialization
Citations

This map shows the geographic impact of Loretto Lacey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loretto Lacey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loretto Lacey more than expected).

Fields of papers citing papers by Loretto Lacey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loretto Lacey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loretto Lacey. The network helps show where Loretto Lacey may publish in the future.

Co-authorship network of co-authors of Loretto Lacey

This figure shows the co-authorship network connecting the top 25 collaborators of Loretto Lacey. A scholar is included among the top collaborators of Loretto Lacey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loretto Lacey. Loretto Lacey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lacey, Loretto, Joel Bobula, Timothy Niecko, & Christopher Leibman. (2016). Informal Care Time and Cost in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer’s Disease: Determinants and Level of Change Observed. Neurology and Therapy. 6(1). 11–23. 7 indexed citations
2.
Rapp, Thomas, et al.. (2015). An Analysis of the Public Financial Support Eligibility Rule for French Dependent Elders with Alzheimer’s Disease. Value in Health. 18(5). 553–559. 6 indexed citations
3.
4.
Brüggenjürgen, Bernd, et al.. (2015). Medical management, costs, and consequences of Alzheimer’s disease in Germany: an analysis of health claims data. Journal of Medical Economics. 18(6). 466–473. 20 indexed citations
5.
Darbà, Josep, et al.. (2014). Relationship between global severity of patients with Alzheimer’s disease and costs of care in Spain; results from the co-dependence study in Spain. The European Journal of Health Economics. 16(8). 895–905. 35 indexed citations
6.
Guo, Shien, et al.. (2014). Evaluating Disease-Modifying Agents: A Simulation Framework for Alzheimer’s Disease. PharmacoEconomics. 32(11). 1129–1139. 19 indexed citations
7.
Gillespie, Paddy, Eamon O’Shea, John Cullinan, et al.. (2014). Longitudinal costs of caring for people with Alzheimer's disease. International Psychogeriatrics. 27(5). 847–856. 23 indexed citations
8.
Lacey, Loretto, et al.. (2013). Association between illness progression measures and total cost in Alzheimer's disease. The journal of nutrition health & aging. 17(9). 745–750. 13 indexed citations
9.
10.
Lenderking, William R., Kathleen W. Wyrwich, Marilyn Stolar, et al.. (2013). Reliability, Validity, and Interpretation of the Dependence Scale in Mild to Moderately Severe Alzheimer’s Disease. American Journal of Alzheimer s Disease & Other Dementias®. 28(8). 738–749. 13 indexed citations
11.
Gerlier, Laetitia, et al.. (2012). PCV65 A Health Economic Evaluation of Omega-3 Acid Ethyl Esters 90 in the Secondary Prevention Post-MI. Value in Health. 15(7). A373–A374. 1 indexed citations
12.
13.
Mhaoláin, Aine M. Ní, Damien Gallagher, Lisa Crosby, et al.. (2011). Correlates of frailty in Alzheimer's disease and mild cognitive impairment. Age and Ageing. 40(5). 630–633. 17 indexed citations
14.
Gallagher, Damien, Áine Ní Mhaoláin, Lisa Crosby, et al.. (2011). Dependence and Caregiver Burden in Alzheimer’s Disease and Mild Cognitive Impairment. American Journal of Alzheimer s Disease & Other Dementias®. 26(2). 110–114. 64 indexed citations
15.
Gallagher, Damien, Áine Ní Mhaoláin, Lisa Crosby, et al.. (2011). Self-efficacy for managing dementia may protect against burden and depression in Alzheimer's caregivers. Aging & Mental Health. 15(6). 663–670. 136 indexed citations
16.
17.
18.
Wilson, Koo, John Marriott, Stephen J. Fuller, Loretto Lacey, & David Gillen. (2003). A Model to Assess the Cost Effectiveness of Statins in Achieving the UK National Service Framework Target Cholesterol Levels. PharmacoEconomics. 21(Supplement 1). 1–11. 16 indexed citations
19.
Lacey, Loretto. (2002). Economic Impact of Treating Inhibitor Patients. Pathophysiology of Haemostasis and Thrombosis. 32(Suppl. 1). 29–32. 8 indexed citations
20.
Aoki, Fred Y., et al.. (2000). Impact of Zanamivir Treatment on Productivity, Health Status and Healthcare Resource Use in Patients with Influenza. PharmacoEconomics. 17(2). 187–195. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cadja Bachmann Breakdown of academic impact, for papers by Allan Gustavo Brígola Breakdown of academic impact, for papers by Carla J.M. Schölzel-Dorenbos Breakdown of academic impact, for papers by KlaasJan Hajema Breakdown of academic impact, for papers by Marisa Silvana Zazzetta Breakdown of academic impact, for papers by Anne‐Marie Burn Breakdown of academic impact, for papers by Silke Mamone Breakdown of academic impact, for papers by Ana Carolina Ottaviani Breakdown of academic impact, for papers by Claudio Bilotta Breakdown of academic impact, for papers by Joseph Parks
Rankless by CCL
2026